| calcium-dependent cysteine-type endopeptidase inhibitor activity |
| negative regulation of type B pancreatic cell apoptotic process |
| presynaptic active zone organization |
| regulation of type B pancreatic cell apoptotic process |
| inhibition of cysteine-type endopeptidase activity |
| zymogen inhibition |
| negative regulation of protein processing |
| negative regulation of protein maturation |
| endopeptidase inhibitor activity |
| negative regulation of epithelial cell apoptotic process |
| regulation of protein processing |
| regulation of protein maturation |
| regulation of epithelial cell apoptotic process |
| negative regulation of cysteine-type endopeptidase activity |
| protease binding |
| regulation of cysteine-type endopeptidase activity |
| negative regulation of endopeptidase activity |
| negative regulation of peptidase activity |
| synapse organization |
| cadherin binding |
| negative regulation of proteolysis |
| regulation of endopeptidase activity |
| regulation of peptidase activity |
| negative regulation of hydrolase activity |
| regulation of proteolysis |
| negative regulation of catalytic activity |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| negative regulation of cell death |
| endoplasmic reticulum |
| negative regulation of cellular protein metabolic process |
| negative regulation of protein metabolic process |
| negative regulation of molecular function |
| regulation of hydrolase activity |
| RNA binding |
| regulation of apoptotic process |
| regulation of programmed cell death |
| regulation of cell death |
| negative regulation of gene expression |
| membrane |